别名 Infection, Soft Tissue、Infections, Soft Tissue、SOFT TISSUE INFECTION + [19] |
简介 Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p1688) |
作用机制 50S subunit抑制剂 [+1] |
原研机构 |
在研适应症 |
最高研发阶段批准上市 |
首次获批国家/地区 中国 |
首次获批日期2021-06-01 |
靶点 |
作用机制 PBPs抑制剂 |
在研适应症 |
最高研发阶段批准上市 |
首次获批国家/地区 加拿大 |
首次获批日期2018-03-20 |
靶点 |
作用机制 PBPs抑制剂 [+1] |
在研机构 |
最高研发阶段批准上市 |
首次获批国家/地区 美国 |
首次获批日期2010-10-29 |
开始日期2024-10-31 |
申办/合作机构 |
开始日期2024-07-17 |
申办/合作机构 |
开始日期2024-07-15 |